Company / Shares Outstanding
Aquestive Therapeutics, Inc. Shares Outstanding History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
91.4M
FY2025
5-year range
34.6M / 91.4M
FY2021-FY2025
Trend
+33.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding has increased for 6 consecutive years, from 24957309.00 in FY2019 to 91413742.00 in FY2025.
Based on SEC 10-K filings.
91413742.00 in FY2025 with a 5-year CAGR of +22.2%.
Increased from 54827734.00 to 91413742.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +30.4%
- 5-Year CAGR
- +22.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- Aquestive Therapeutics, Inc.'s shares outstanding has grown for 6 consecutive years.
- In FY2025, shares outstanding increased 33.4% year-over-year.
- Lowest shares outstanding in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 91.4M | +33.4% |
| FY2024 | 68.5M | +25.0% |
| FY2023 | 54.8M | +33.0% |
| FY2022 | 41.2M | +19.3% |
| FY2021 | 34.6M | +3.0% |
| FY2020 | 33.6M | +34.5% |
| FY2019 | 25.0M | +0.0% |
| FY2018 | 25.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026